Skip to main content
Top
Published in: BMC Clinical Pharmacology 1/2009

Open Access 01-12-2009 | Research article

The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty

Authors: Miran Brvar, Nina Fokter, Matjaz Bunc, Martin Mozina

Published in: BMC Clinical Pharmacology | Issue 1/2009

Login to get access

Abstract

Background

Adverse Drug Reactions (ADRs) have been regarded as a major public health problem since they represent a sizable percentage of admissions. Unfortunately, there is a wide variation of ADR related admissions among different studies. The aim of this study was to evaluate the frequency of ADR related admissions and its dependency on reporting and method of detection, urgency of admissions and included medical departments reflecting department/hospital type within one study.

Methods

The study team of internal medicine specialists retrospectively reviewed 520 randomly selected medical records (3%) of patients treated in the medical departments of the primary city and tertiary referral governmental hospital for certain ADRs causing admissions regarding WHO causality criteria. All medical records were checked for whether the treating physicians recognised and documented ADRs causing admissions. The hospital information system was checked to ensure ADR related diagnoses were properly coded and the database of a national spontaneous reporting system was searched for patients with ADRs included in this study.

Results

The established frequency of admissions due to certain ADRs recognised by the study team and documented in medical records by the treating physicians was the same and represented 5.8% of all patients (30/520). The frequency of ADR causing admissions detected by employing a computer-assisted approach using an ICD-10 coding system was 0.2% (1/520), and no patient admitted due to ADRs was reported to the national reporting system (0/520). The recognized frequency of ADR related admissions also depends on the department's specialty (p = 0.001) and acceptance of urgently admitted patients (p = 0.001). Patients admitted due to ADRs were significantly older compared to patients without ADRs (p = 0.025). Gastrointestinal bleeding due to NSAID, acetylsalicylic acid and warfarin was the most common ADR that resulted in admission and represented 40% of all certain ADRs (12/30) according to WHO causality criteria.

Conclusion

ADRs cause 5.8% of admissions in medical departments in the primary city and tertiary referral hospital. The physicians recognise certain ADR related admissions according to WHO causality criteria and note them in medical records, but they rarely code and report ADRs. The established frequency of ADR related admissions depends on the detection method, department specialty and frequency of urgently admitted patients.
Literature
1.
go back to reference Camargo AL, Cardoso Ferreira MB, Heineck I: Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol. 2006, 62: 143-149. 10.1007/s00228-005-0086-7.CrossRefPubMed Camargo AL, Cardoso Ferreira MB, Heineck I: Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol. 2006, 62: 143-149. 10.1007/s00228-005-0086-7.CrossRefPubMed
2.
go back to reference Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ: Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007, 7: 8-10.1186/1472-6904-7-8.CrossRefPubMedPubMedCentral Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ: Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007, 7: 8-10.1186/1472-6904-7-8.CrossRefPubMedPubMedCentral
3.
go back to reference Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A: Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol. 2007, 7: 9-10.1186/1472-6904-7-9.CrossRefPubMedPubMedCentral Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A: Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol. 2007, 7: 9-10.1186/1472-6904-7-9.CrossRefPubMedPubMedCentral
4.
go back to reference Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004, 329: 15-19. 10.1136/bmj.329.7456.15.CrossRefPubMedPubMedCentral Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004, 329: 15-19. 10.1136/bmj.329.7456.15.CrossRefPubMedPubMedCentral
5.
go back to reference Pouyanne P, Haramburu F, Imbs JL, Bégaud B: Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ. 2000, 320: 1036-10.1136/bmj.320.7241.1036.CrossRefPubMedPubMedCentral Pouyanne P, Haramburu F, Imbs JL, Bégaud B: Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ. 2000, 320: 1036-10.1136/bmj.320.7241.1036.CrossRefPubMedPubMedCentral
6.
go back to reference Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Tröger M, Azaz-Livshits T, Levy M, Brune K, Hahn EG: Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med. 2004, 255: 653-663. 10.1111/j.1365-2796.2004.01326.x.CrossRefPubMed Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Tröger M, Azaz-Livshits T, Levy M, Brune K, Hahn EG: Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med. 2004, 255: 653-663. 10.1111/j.1365-2796.2004.01326.x.CrossRefPubMed
7.
go back to reference Fattinger K, Roos M, Vergères P, Holenstein C, Kind B, Masche U, Stocker DN, Braunschweig S, Kullak-Ublick GA, Galeazzi RL, Follath F, Gasser T, Meier PJ: Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol. 2000, 49: 158-167. 10.1046/j.1365-2125.2000.00132.x.CrossRefPubMedPubMedCentral Fattinger K, Roos M, Vergères P, Holenstein C, Kind B, Masche U, Stocker DN, Braunschweig S, Kullak-Ublick GA, Galeazzi RL, Follath F, Gasser T, Meier PJ: Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol. 2000, 49: 158-167. 10.1046/j.1365-2125.2000.00132.x.CrossRefPubMedPubMedCentral
8.
go back to reference Grenouillet-Delacre M, Verdoux H, Moore N, Haramburu F, Miremont-Salamé G, Etienne G, Robinson P, Gruson D, Hilbert G, Gabinski C, Bégaud B, Molimard M: Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med. 2007, 33: 2150-2157. 10.1007/s00134-007-0787-8.CrossRefPubMed Grenouillet-Delacre M, Verdoux H, Moore N, Haramburu F, Miremont-Salamé G, Etienne G, Robinson P, Gruson D, Hilbert G, Gabinski C, Bégaud B, Molimard M: Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital. Intensive Care Med. 2007, 33: 2150-2157. 10.1007/s00134-007-0787-8.CrossRefPubMed
9.
go back to reference Muehlberger N, Schneeweiss S, Hasford J: Adverse drug reaction monitoring – cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997, 6 (Suppl 3): S71-77. 10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9.CrossRefPubMed Muehlberger N, Schneeweiss S, Hasford J: Adverse drug reaction monitoring – cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf. 1997, 6 (Suppl 3): S71-77. 10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9.CrossRefPubMed
10.
go back to reference World Health Organisation: Safety of Medicine: a guide to detecting and reporting adverse drug reaction. 2002, WHO Geneva World Health Organisation: Safety of Medicine: a guide to detecting and reporting adverse drug reaction. 2002, WHO Geneva
11.
go back to reference Edwards IR, Biriell C: Harmonisation in Pharmacovigilance. Drug Safety. 1994, 10: 93-102. 10.2165/00002018-199410020-00001.CrossRefPubMed Edwards IR, Biriell C: Harmonisation in Pharmacovigilance. Drug Safety. 1994, 10: 93-102. 10.2165/00002018-199410020-00001.CrossRefPubMed
12.
go back to reference Passarelli MC, Jacob-Filho W, Figueras A: Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005, 22: 767-777. 10.2165/00002512-200522090-00005.CrossRefPubMed Passarelli MC, Jacob-Filho W, Figueras A: Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005, 22: 767-777. 10.2165/00002512-200522090-00005.CrossRefPubMed
13.
go back to reference Waller P, Shaw M, Ho D, Shakir S, Ebrahim S: Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol. 2005, 59: 213-219. 10.1111/j.1365-2125.2004.02236.x.CrossRefPubMedPubMedCentral Waller P, Shaw M, Ho D, Shakir S, Ebrahim S: Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol. 2005, 59: 213-219. 10.1111/j.1365-2125.2004.02236.x.CrossRefPubMedPubMedCentral
14.
go back to reference Hooft van der CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BH: Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf. 2006, 29: 161-168. 10.2165/00002018-200629020-00006.CrossRefPubMed Hooft van der CS, Sturkenboom MC, van Grootheest K, Kingma HJ, Stricker BH: Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf. 2006, 29: 161-168. 10.2165/00002018-200629020-00006.CrossRefPubMed
15.
go back to reference Alvarez-Requejo A, Carvajal A, Bégaud B, Moride Y, Vega T, Arias LH: Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol. 1998, 54: 483-488. 10.1007/s002280050498.CrossRefPubMed Alvarez-Requejo A, Carvajal A, Bégaud B, Moride Y, Vega T, Arias LH: Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol. 1998, 54: 483-488. 10.1007/s002280050498.CrossRefPubMed
16.
go back to reference Hazell L, Shakir SA: Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006, 29: 385-396. 10.2165/00002018-200629050-00003.CrossRefPubMed Hazell L, Shakir SA: Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006, 29: 385-396. 10.2165/00002018-200629050-00003.CrossRefPubMed
17.
go back to reference von Euler M, Eliasson E, Ohlén G, Bergman U: Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006, 15: 179-184. 10.1002/pds.1154.CrossRefPubMed von Euler M, Eliasson E, Ohlén G, Bergman U: Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006, 15: 179-184. 10.1002/pds.1154.CrossRefPubMed
18.
go back to reference Pedrós C, Vallano A, Cereza G, Mendoza-Aran G, Agustí A, Aguilera C, Danés I, Vidal X, Arnau JM: An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009, 32: 77-83. 10.2165/00002018-200932010-00007.CrossRefPubMed Pedrós C, Vallano A, Cereza G, Mendoza-Aran G, Agustí A, Aguilera C, Danés I, Vidal X, Arnau JM: An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009, 32: 77-83. 10.2165/00002018-200932010-00007.CrossRefPubMed
19.
go back to reference Cox AR, Anton C, Goh CH, Easter M, Langford NJ, Ferner RE: Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol. 2001, 52: 337-339. 10.1046/j.0306-5251.2001.01454.x.CrossRefPubMedPubMedCentral Cox AR, Anton C, Goh CH, Easter M, Langford NJ, Ferner RE: Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol. 2001, 52: 337-339. 10.1046/j.0306-5251.2001.01454.x.CrossRefPubMedPubMedCentral
20.
go back to reference Brown EG: Dictionaries and coding in pharmacovigilance. Stephen's Detection of New Adverse Drug Reactions. Edited by: Talbot J, Waller P. 2004, Chichester: Wiley, 533-557. Brown EG: Dictionaries and coding in pharmacovigilance. Stephen's Detection of New Adverse Drug Reactions. Edited by: Talbot J, Waller P. 2004, Chichester: Wiley, 533-557.
21.
go back to reference Jorup-Rönström C, Keisu M, Wiholm BE: Could Swedish 'yellow cards' be substituted by E-coded summaries?. Drug Saf. 1990, 5: 72-77. 10.2165/00002018-199005010-00007.CrossRefPubMed Jorup-Rönström C, Keisu M, Wiholm BE: Could Swedish 'yellow cards' be substituted by E-coded summaries?. Drug Saf. 1990, 5: 72-77. 10.2165/00002018-199005010-00007.CrossRefPubMed
22.
go back to reference McGettigan P, Golden J, Conroy RM, Arthur N, Feely J: Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997, 44: 98-100. 10.1046/j.1365-2125.1997.00616.x.CrossRefPubMedPubMedCentral McGettigan P, Golden J, Conroy RM, Arthur N, Feely J: Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997, 44: 98-100. 10.1046/j.1365-2125.1997.00616.x.CrossRefPubMedPubMedCentral
23.
go back to reference Furst J, Samaluk V: Predpisovanje zdravil v letu 2006. Zdrav Vestn. 2007, 76: 487-492. Furst J, Samaluk V: Predpisovanje zdravil v letu 2006. Zdrav Vestn. 2007, 76: 487-492.
24.
go back to reference Howard RL, Avery AJ, Howard PD, Partridge M: Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003, 12: 280-285. 10.1136/qhc.12.4.280.CrossRefPubMedPubMedCentral Howard RL, Avery AJ, Howard PD, Partridge M: Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003, 12: 280-285. 10.1136/qhc.12.4.280.CrossRefPubMedPubMedCentral
25.
go back to reference Beijer HJ, de Blaey CJ: Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002, 24: 46-54. 10.1023/A:1015570104121.CrossRefPubMed Beijer HJ, de Blaey CJ: Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002, 24: 46-54. 10.1023/A:1015570104121.CrossRefPubMed
26.
go back to reference Le J, Nguyen T, Law AV, Hodding J: Adverse drug reactions among children over a 10-year period. Pediatrics. 2006, 118: 555-562. 10.1542/peds.2005-2429.CrossRefPubMed Le J, Nguyen T, Law AV, Hodding J: Adverse drug reactions among children over a 10-year period. Pediatrics. 2006, 118: 555-562. 10.1542/peds.2005-2429.CrossRefPubMed
27.
go back to reference Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998, 279: 1200-1205. 10.1001/jama.279.15.1200.CrossRefPubMed Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998, 279: 1200-1205. 10.1001/jama.279.15.1200.CrossRefPubMed
28.
go back to reference Routledge PA, O'Mahony MS, Woodhouse KW: Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004, 57: 121-126. 10.1046/j.1365-2125.2003.01875.x.CrossRefPubMedPubMedCentral Routledge PA, O'Mahony MS, Woodhouse KW: Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004, 57: 121-126. 10.1046/j.1365-2125.2003.01875.x.CrossRefPubMedPubMedCentral
29.
go back to reference Rivkin A: Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm. 2007, 64: 1840-1843. 10.2146/ajhp060641.CrossRefPubMed Rivkin A: Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm. 2007, 64: 1840-1843. 10.2146/ajhp060641.CrossRefPubMed
Metadata
Title
The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty
Authors
Miran Brvar
Nina Fokter
Matjaz Bunc
Martin Mozina
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Clinical Pharmacology / Issue 1/2009
Electronic ISSN: 1472-6904
DOI
https://doi.org/10.1186/1472-6904-9-8

Other articles of this Issue 1/2009

BMC Clinical Pharmacology 1/2009 Go to the issue